Skip to main content
Erschienen in: Infection 2/2013

01.04.2013 | Clinical and Epidemiological Study

Compliance with antimalarial chemoprophylaxis in German soldiers: a 6-year survey

verfasst von: H. Frickmann, N. G. Schwarz, H.-U. Holtherm, W. Maaßen, F. Vorderwülbecke, K. Erkens, M. Fischer, T. Morwinsky, R. M. Hagen

Erschienen in: Infection | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Since 1992, German soldiers have been deployed in areas where malaria is endemic. Antimalarial chemoprophylaxis (CP) is directed according to the assessed risk and is provided free of charge. Compliance is crucial if its effect is to be reliable. This study analysed compliance with directed CP in German soldiers as well as its determinants.

Methods

Between 2003 and 2009, standardized questionnaire-based interviews were performed with 2,149 out of approximately 100,000 German soldiers who were deployed during this period in areas where malaria is endemic. The questionnaires dealt with information that the soldiers had received about malaria prior to their missions, with their adherence to mosquito-protective and antimalarial chemoprophylactic procedures, and their estimations of their individual level of exposure.

Results

About 1,308 out of 2,149 interviewed soldiers had been ordered to take CP, allowing for an assessment of the outcome parameter “CP-compliance”. About 76.9 % out of 1,308 soldiers to whom regular CP was directed took it regularly. The exposure variables “age”, “satisfaction with malaria counselling”, “perceived threat due to insects or mosquitoes” and “use of insect repellents” were positively associated with compliance with directed antimalarial CP.

Conclusions

The study confirms the findings of the French and US armies that even free-of-charge access to antimalarial medication will not lead to 100 % acceptance. The compliance problem is aggravated by the generally low age of deployed soldiers. Adequate counselling is crucial to increase adherence to antimalarial CP.
Literatur
1.
Zurück zum Zitat Rey S, Zuza I, Martinez-Mondejar B, Rubio JM, Merino FJ. Imported malaria in an area in southern Madrid, 2005–2008. Malar J. 2010;9:290.PubMedCrossRef Rey S, Zuza I, Martinez-Mondejar B, Rubio JM, Merino FJ. Imported malaria in an area in southern Madrid, 2005–2008. Malar J. 2010;9:290.PubMedCrossRef
2.
Zurück zum Zitat Bueno Mari R, Jimenez Peydro R. Pueden la malaria y el dengue reaparecer en Espana? Gac Sanit. 2010;24:347–53. Bueno Mari R, Jimenez Peydro R. Pueden la malaria y el dengue reaparecer en Espana? Gac Sanit. 2010;24:347–53.
3.
Zurück zum Zitat Santa-Olalla Peralta P, Vazquez-Torres MC, Latorre-Fandos E, Mairal-Claver P, Cortina-Solano P, Puy-Azon A, Adiego Sancho B, Leitmeyer K, Lucientes-Curdi J, Sierra-Moros MJ. First autochthonous malaria case due to Plasmodium vivax since eradication, Spain, October 2010. Euro Surveill. 2010;15:19684. Santa-Olalla Peralta P, Vazquez-Torres MC, Latorre-Fandos E, Mairal-Claver P, Cortina-Solano P, Puy-Azon A, Adiego Sancho B, Leitmeyer K, Lucientes-Curdi J, Sierra-Moros MJ. First autochthonous malaria case due to Plasmodium vivax since eradication, Spain, October 2010. Euro Surveill. 2010;15:19684.
4.
Zurück zum Zitat Schoneberg I, Stark K, Altmann D, Krause G. [Malaria in Germany 1993 to 2003. Data from the Robert Koch Institute on affected groups of people, countries traveled to and treatment]. Dtsch Med Wochenschr. 2005;130:937–41. Schoneberg I, Stark K, Altmann D, Krause G. [Malaria in Germany 1993 to 2003. Data from the Robert Koch Institute on affected groups of people, countries traveled to and treatment]. Dtsch Med Wochenschr. 2005;130:937–41.
5.
Zurück zum Zitat van Rijckevorsel GG, Sonder GJ, Geskus RB, Wetsteyn JC, Ligthelm RJ, Visser LG, Keuter M, van Genderen PJ, van den Hoek A. Declining incidence of imported malaria in the Netherlands, 2000–2007. Malar J. 2010;9:300.PubMedCrossRef van Rijckevorsel GG, Sonder GJ, Geskus RB, Wetsteyn JC, Ligthelm RJ, Visser LG, Keuter M, van Genderen PJ, van den Hoek A. Declining incidence of imported malaria in the Netherlands, 2000–2007. Malar J. 2010;9:300.PubMedCrossRef
6.
Zurück zum Zitat Bruneel F, Tubach F, Corne P, Megarbane B, Mira JP, Peytel E, Camus C, Schortgen F, Azoulay E, Cohen Y, Georges H, Meybeck A, Hyvernat H, Trouillet JL, Frenoy E, Nicolet L, Roy C, Durand R, Le Bras J, Wolff M, Severe Imported Malaria in Adults (SIMA) Study Group. Severe imported falciparum malaria: a cohort study in 400 critically ill adults. PLoS ONE. 2010;5:e13236.PubMedCrossRef Bruneel F, Tubach F, Corne P, Megarbane B, Mira JP, Peytel E, Camus C, Schortgen F, Azoulay E, Cohen Y, Georges H, Meybeck A, Hyvernat H, Trouillet JL, Frenoy E, Nicolet L, Roy C, Durand R, Le Bras J, Wolff M, Severe Imported Malaria in Adults (SIMA) Study Group. Severe imported falciparum malaria: a cohort study in 400 critically ill adults. PLoS ONE. 2010;5:e13236.PubMedCrossRef
7.
Zurück zum Zitat Widmer LL, Blank PR, Van Herck K, Hatz C, Schlagenhauf P. Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa. BMC Infect Dis. 2010;10:279.PubMedCrossRef Widmer LL, Blank PR, Van Herck K, Hatz C, Schlagenhauf P. Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa. BMC Infect Dis. 2010;10:279.PubMedCrossRef
8.
Zurück zum Zitat Krause G, Schoneberg I, Altmann D, Stark K. Chemoprophylaxis and malaria death rates. Emerg Infect Dis. 2006;12:447–51.PubMedCrossRef Krause G, Schoneberg I, Altmann D, Stark K. Chemoprophylaxis and malaria death rates. Emerg Infect Dis. 2006;12:447–51.PubMedCrossRef
10.
Zurück zum Zitat Legros F, Bouchaud O, Ancelle T, Arnaud A, Cojean S, Le Bras J, Danis M, Fontanet A, Durand R. Risk factors for imported fatal Plasmodium falciparum malaria, France, 1996–2003. Emerg Infect Dis. 2007;13:883–8.PubMedCrossRef Legros F, Bouchaud O, Ancelle T, Arnaud A, Cojean S, Le Bras J, Danis M, Fontanet A, Durand R. Risk factors for imported fatal Plasmodium falciparum malaria, France, 1996–2003. Emerg Infect Dis. 2007;13:883–8.PubMedCrossRef
11.
Zurück zum Zitat Croft AM, Garner P. Mefloquine for preventing malaria in non-immune adult travellers. Cochrane Database Syst Rev. 2000;4:CD000138. Croft AM, Garner P. Mefloquine for preventing malaria in non-immune adult travellers. Cochrane Database Syst Rev. 2000;4:CD000138.
12.
Zurück zum Zitat Hopperus Buma AP, van Thiel PP, Lobel HO, Ohrt C, van Ameijden EJ, Veltink RL, Tendeloo DC, van Gool T, Green MD, Todd GD, Kyle DE, Kager PA. Long-term malaria chemoprophylaxis with mefloquine in Dutch marines in Cambodia. J Infect Dis. 1996;173:1506–9. Hopperus Buma AP, van Thiel PP, Lobel HO, Ohrt C, van Ameijden EJ, Veltink RL, Tendeloo DC, van Gool T, Green MD, Todd GD, Kyle DE, Kager PA. Long-term malaria chemoprophylaxis with mefloquine in Dutch marines in Cambodia. J Infect Dis. 1996;173:1506–9.
13.
Zurück zum Zitat Schlagenhauf P, Adamcova M, Regep L, Schaerer MT, Rhein HG. The position of mefloquine as a 21st century malaria chemoprophylaxis. Malar J. 2010;9:357.PubMedCrossRef Schlagenhauf P, Adamcova M, Regep L, Schaerer MT, Rhein HG. The position of mefloquine as a 21st century malaria chemoprophylaxis. Malar J. 2010;9:357.PubMedCrossRef
14.
Zurück zum Zitat Nakato H, Vivancos R, Hunter PR. A systematic review and meta-analysis of the effectiveness and safety of atovaquone proguanil (Malarone) for chemoprophylaxis against malaria. J Antimicrob Chemother. 2007;60:929–36.PubMedCrossRef Nakato H, Vivancos R, Hunter PR. A systematic review and meta-analysis of the effectiveness and safety of atovaquone proguanil (Malarone) for chemoprophylaxis against malaria. J Antimicrob Chemother. 2007;60:929–36.PubMedCrossRef
15.
Zurück zum Zitat Overbosch D, Schilthuis H, Bienzle U, Behrens RH, Kain KC, Clarke PD, Toovey S, Knobloch J, Nothdurft HD, Shaw D, Roskell NS. Malarone International Study Team. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study. Clin Infect Dis. 2001;33:1015–21.PubMedCrossRef Overbosch D, Schilthuis H, Bienzle U, Behrens RH, Kain KC, Clarke PD, Toovey S, Knobloch J, Nothdurft HD, Shaw D, Roskell NS. Malarone International Study Team. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study. Clin Infect Dis. 2001;33:1015–21.PubMedCrossRef
16.
Zurück zum Zitat Sonmez A, Harlak A, Kilic S, Polat Z, Hayat L, Keskin O, Dogru T, Yilmaz MI, Acikel CH, Kocar IH. The efficacy and tolerability of doxycycline and mefloquine in malaria prophylaxis of the ISAF troops in Afghanistan. J Infect. 2005;51:253–8.PubMedCrossRef Sonmez A, Harlak A, Kilic S, Polat Z, Hayat L, Keskin O, Dogru T, Yilmaz MI, Acikel CH, Kocar IH. The efficacy and tolerability of doxycycline and mefloquine in malaria prophylaxis of the ISAF troops in Afghanistan. J Infect. 2005;51:253–8.PubMedCrossRef
17.
Zurück zum Zitat Whitman TJ, Coyne PE, Magill AJ, Blazes DL, Green MD, Milhous WK, Burgess TH, Freilich D, Tasker SA, Azar RG, Endy TP, Clagett CD, Deye GA, Shanks GD, Martin GJ. An outbreak of Plasmodium falciparum malaria in US marines deployed to Liberia. Am J Trop Med Hyg. 2010;83:258–65.PubMedCrossRef Whitman TJ, Coyne PE, Magill AJ, Blazes DL, Green MD, Milhous WK, Burgess TH, Freilich D, Tasker SA, Azar RG, Endy TP, Clagett CD, Deye GA, Shanks GD, Martin GJ. An outbreak of Plasmodium falciparum malaria in US marines deployed to Liberia. Am J Trop Med Hyg. 2010;83:258–65.PubMedCrossRef
18.
Zurück zum Zitat Bellanger AP, Faucher JF, Robedat P, Schmitt A, Millon L, Hoen B. Malaria outbreak in French troops returning from Côte d’Ivoire. Scand J Infect Dis. 2011;43:230–3.PubMedCrossRef Bellanger AP, Faucher JF, Robedat P, Schmitt A, Millon L, Hoen B. Malaria outbreak in French troops returning from Côte d’Ivoire. Scand J Infect Dis. 2011;43:230–3.PubMedCrossRef
19.
Zurück zum Zitat Hagen RM, Fischer M, Bronnert J, Wiemer D, Krueger A, Harbaum T. Medical support during EUFOR DR Congo: In-theatre experience and follow-up, first results. 5th ECTMIH. 2007;O28–12. Hagen RM, Fischer M, Bronnert J, Wiemer D, Krueger A, Harbaum T. Medical support during EUFOR DR Congo: In-theatre experience and follow-up, first results. 5th ECTMIH. 2007;O28–12.
20.
Zurück zum Zitat Faulde MK, Heyl G, Amirih ML. Zoonotic cutaneus leishmaniasis, Afghanistan. Emerg Infect Dis. 2006;12:1623–4.PubMedCrossRef Faulde MK, Heyl G, Amirih ML. Zoonotic cutaneus leishmaniasis, Afghanistan. Emerg Infect Dis. 2006;12:1623–4.PubMedCrossRef
21.
Zurück zum Zitat Alon D, Shitrit P, Chowers M. Risk behaviors and spectrum of diseases among elderly travelers: a comparison of younger and older adults. J Travel Med. 2010;17:250–5.PubMedCrossRef Alon D, Shitrit P, Chowers M. Risk behaviors and spectrum of diseases among elderly travelers: a comparison of younger and older adults. J Travel Med. 2010;17:250–5.PubMedCrossRef
22.
Zurück zum Zitat Pistone T, Ezzedine K, Gaudin AF, Hercberg S, Nachbaur G, Malvy D. Malaria prevention behaviour and risk awareness in French adult travellers. Travel Med Infect Dis. 2010;8:13–21.PubMedCrossRef Pistone T, Ezzedine K, Gaudin AF, Hercberg S, Nachbaur G, Malvy D. Malaria prevention behaviour and risk awareness in French adult travellers. Travel Med Infect Dis. 2010;8:13–21.PubMedCrossRef
23.
Zurück zum Zitat Ropers G, Du Ry van Beest Holle M, Wichmann O, Kappelmayer L, Stuben U, Schonfeld C, Stark K. Determinants of malaria prophylaxis among German travelers to Kenya, Senegal, and Thailand. J Travel Med. 2008;15:162–71.PubMedCrossRef Ropers G, Du Ry van Beest Holle M, Wichmann O, Kappelmayer L, Stuben U, Schonfeld C, Stark K. Determinants of malaria prophylaxis among German travelers to Kenya, Senegal, and Thailand. J Travel Med. 2008;15:162–71.PubMedCrossRef
24.
Zurück zum Zitat Mayet A, Lacassagne D, Juzan N, Chaudier B, Haus-Cheymol R, Berger F, Romand O, Ollivier L, Verret C, Deparis X, Spiegel A. Malaria outbreak among French army troops returning from the Ivory Coast. J Travel Med. 2010;17:353–5.PubMedCrossRef Mayet A, Lacassagne D, Juzan N, Chaudier B, Haus-Cheymol R, Berger F, Romand O, Ollivier L, Verret C, Deparis X, Spiegel A. Malaria outbreak among French army troops returning from the Ivory Coast. J Travel Med. 2010;17:353–5.PubMedCrossRef
25.
Zurück zum Zitat Kotwal RS, Wenzel RB, Sterling RA, Porter WD, Jordan NN, Petruccelli BP. An outbreak of malaria in US army rangers returning from Afghanistan. JAMA. 2005;293:212–6.PubMedCrossRef Kotwal RS, Wenzel RB, Sterling RA, Porter WD, Jordan NN, Petruccelli BP. An outbreak of malaria in US army rangers returning from Afghanistan. JAMA. 2005;293:212–6.PubMedCrossRef
26.
Zurück zum Zitat Andersson H, Askling HH, Falck B, Rombo L. Well-tolerated chemoprophylaxis uniformly prevented Swedish soldiers from Plasmodium falciparum malaria in Liberia, 2004–2006. Mil Med. 2008;173:1194–8.PubMed Andersson H, Askling HH, Falck B, Rombo L. Well-tolerated chemoprophylaxis uniformly prevented Swedish soldiers from Plasmodium falciparum malaria in Liberia, 2004–2006. Mil Med. 2008;173:1194–8.PubMed
27.
Zurück zum Zitat Resseguier N, Machault V, Ollivier L, Orlandi-Pradines E, Texier G, Pradines B, Gaudart J, Buguet A, Tourette-Turgis C, Rogier C. Determinants of compliance with malaria chemoprophylaxis among French soldiers during missions in inter-tropical Africa. Malar J. 2010;9:41.PubMedCrossRef Resseguier N, Machault V, Ollivier L, Orlandi-Pradines E, Texier G, Pradines B, Gaudart J, Buguet A, Tourette-Turgis C, Rogier C. Determinants of compliance with malaria chemoprophylaxis among French soldiers during missions in inter-tropical Africa. Malar J. 2010;9:41.PubMedCrossRef
28.
Zurück zum Zitat Ollivier L, Michel R, Carlotti MP, Mahe P, Romand O, Todesco A, Migliani R, Boutin JP. Chemoprophylaxis compliance in a French battalion after returning from malaria-endemic area. J Travel Med. 2008;15:355–7.PubMedCrossRef Ollivier L, Michel R, Carlotti MP, Mahe P, Romand O, Todesco A, Migliani R, Boutin JP. Chemoprophylaxis compliance in a French battalion after returning from malaria-endemic area. J Travel Med. 2008;15:355–7.PubMedCrossRef
Metadaten
Titel
Compliance with antimalarial chemoprophylaxis in German soldiers: a 6-year survey
verfasst von
H. Frickmann
N. G. Schwarz
H.-U. Holtherm
W. Maaßen
F. Vorderwülbecke
K. Erkens
M. Fischer
T. Morwinsky
R. M. Hagen
Publikationsdatum
01.04.2013
Verlag
Springer-Verlag
Erschienen in
Infection / Ausgabe 2/2013
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-013-0411-5

Weitere Artikel der Ausgabe 2/2013

Infection 2/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.